Author:
van Gennip A. H.,Stroomer A.,Plandsoen W. G.,Abeling N. G. G. M.
Subject
Genetics (clinical),Genetics
Reference5 articles.
1. Al-Khalidi, U. A. S. and Chaglassian, T. H. The species distribution of xanthine oxidase.Biochem. J. 97 (1965) 318–320
2. Jimenez, M. L., Puig, J. G., Mateos, F. A., Ramos, T. H., Castroviejo, I. P. and Vazquez, J. O. Hypoxanthine and xanthine transport through the blood-brain barrier in hypoxanthine phosphoribosyl transferase deficiency.Adv. Exp. Med. Biol. 253A (1989) 173–179
3. Mudd, S. H., Irreverre, F. and Laster, L. Sulfite oxidase deficiency in man: Demonstration of the enzymatic defect.Science 156 (1967) 1599–1602
4. Van Gennip, A. H., Van Noordenburg-Huistra, D. Y., De Bree, P. K. and Wadman, S. K. Two-dimensional thin layer chromatography for the screening of disorders of purine and pyrimidine metabolism.Clin. Chim. Acta 86 (1978) 7–20
5. Van Gennip, A. H. Screening for inborn errors of purine and pyrimidine metabolism by bidimensional TLC and HPLC. In: Krstulovic, A. M. (ed.),Handbook of Chromatography, Nucleic Acids and Related Compounds, CRC Press Inc., Boca Raton, 1987, pp. 221–245
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Molybdenum Cofactor Disorders;Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases;2022
2. Molybdenum Cofactor Disorders;Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases;2013-01-28
3. Effect of Allopurinol on the Xanthinuria in a Patient with Molybdenum Cofactor Deficiency;Purine and Pyrimidine Metabolism in Man VIII;1995
4. The detection of molybdenum cofactor deficiency: Clinical symptomatology and urinary metabolite profile;Journal of Inherited Metabolic Disease;1994-01
5. Molybdenum-Cofactor Deficiency: An Easily Missed Cause of Neonatal Convulsions;Neuropediatrics;1993-06